|
|
||||||||
The Journal of Immunology, Vol 154, Issue 3 1339-1349, Copyright © 1995 by American Association of Immunologists
ARTICLES |
M Miyamasu, K Hirai, Y Takahashi, M Iida, M Yamaguchi, T Koshino, T Takaishi, Y Morita, K Ohta and T Kasahara
Department of Medicine and Physical Therapy, University of Tokyo School of Medicine, Japan.
Recent studies have shown that eosinophils are capable of generating and releasing cytokines, providing a novel biologic aspect of eosinophils for regulating allergic inflammation by an autocrine or paracrine mechanism. Eosinophils synthesize various cytokines; however, the physiologic stimuli that trigger eosinophils to generate cytokines have not been fully elucidated. We examined the effect of chemotactic agonists on eosinophil cytokine generation by employing the determination of IL-8 as the main parameter. Both C5a and FMLP stimulated eosinophils to release IL-8, whereas platelet-activating factor and C-C chemokines did not exert any significant effects. On a molar basis, C5a was two orders of magnitude more potent than FMLP. The generation of IL-8 by chemoattractants was absolutely dependent on the presence of cytochalasin B. Pertussis toxin completely attenuated C5a- and FMLP-induced IL-8 production, indicating the involvement of pertussis toxin-sensitive G-proteins in the signal-transduction process leading to these responses. Experiments of in situ hybridization and PCR amplification revealed that both C5a and FMLP promoted eosinophil IL-8 production through transcriptional gene activation. Pyrrolidine dithiocarbamate completely abrogated chemoattractant-induced IL-8 production, indicating the involvement of NF-kappa B in the cytoplasmic/nuclear signal-transduction process. Furthermore, chemoattractant-induced cytokine production was not limited to IL-8; C5a and FMLP but not platelet-activating factor induced significant secretion of granulocyte-macrophage-CSF from eosinophils. These results indicate that C5a and FMLP stimulate eosinophils to elaborate cytokines, which could be an important mechanism in the regulation of allergic inflammation.
This article has been cited by other articles:
![]() |
A. Dobrina, M. Pausa, F. Fischetti, R. Bulla, E. Vecile, E. Ferrero, A. Mantovani, and F. Tedesco Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo Blood, January 1, 2002; 99(1): 185 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iikura, M. Miyamasu, M. Yamaguchi, H. Kawasaki, K. Matsushima, M. Kitaura, Y. Morita, O. Yoshie, K. Yamamoto, and K. Hirai Chemokine receptors in human basophils: inducible expression of functional CXCR4 J. Leukoc. Biol., July 1, 2001; 70(1): 113 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Kidney and D. Proud Neutrophil Transmigration across Human Airway Epithelial Monolayers . Mechanisms and Dependence on Electrical Resistance Am. J. Respir. Cell Mol. Biol., September 1, 2000; 23(3): 389 - 395. [Abstract] [Full Text] |
||||
![]() |
T. Adachi, B. K. Choudhury, S. Stafford, S. Sur, and R. Alam The Differential Role of Extracellular Signal-Regulated Kinases and p38 Mitogen-Activated Protein Kinase in Eosinophil Functions J. Immunol., August 15, 2000; 165(4): 2198 - 2204. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nagase, M. Miyamasu, M. Yamaguchi, T. Fujisawa, K. Ohta, K. Yamamoto, Y. Morita, and K. Hirai Expression of CXCR4 in Eosinophils: Functional Analyses and Cytokine-Mediated Regulation J. Immunol., June 1, 2000; 164(11): 5935 - 5943. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Munoz, K. J. Hamann, K. F. Rabe, H. Sano, X. Zhu, and A. R. Leff Augmentation of eosinophil degranulation and LTC4 secretion by integrin-mediated endothelial cell adhesion Am J Physiol Lung Cell Mol Physiol, October 1, 1999; 277(4): L802 - L810. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miyamasu, M. Yamaguchi, T. Nakajima, Y. Misaki, Y. Morita, K. Matsushima, K. Yamamoto, and K. Hirai Th1-derived cytokine IFN-{gamma} is a potent inhibitor of eotaxin synthesis in vitro Int. Immunol., June 1, 1999; 11(6): 1001 - 1004. [Abstract] [Full Text] |
||||
![]() |
M. A. Giembycz and M. A. Lindsay Pharmacology of the Eosinophil Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. MURAI, Y. MUNAKATA, Y. TAKAHASHI, T. ISHII, S. SHIBATA, T. MURYOI, T. FUNATO, M. NAKAMURA, K. SUGAMURA, and T. SASAKI Rheumatoid arthritis after human parvovirus B19 infection Ann Rheum Dis, February 1, 1999; 58(2): 130 - 130. [Full Text] |
||||
![]() |
H. Petering, O. Gotze, D. Kimmig, R. Smolarski, A. Kapp, and J. Elsner The Biologic Role of Interleukin-8: Functional Analysis and Expression of CXCR1 and CXCR2 on Human Eosinophils Blood, January 15, 1999; 93(2): 694 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhu, K. J. Hamann, N. M. Munoz, N. Rubio, D. Mayer, A. Hernrreiter, and A. R. Leff Intracellular Expression of Fc{gamma}RIII (CD16) and Its Mobilization by Chemoattractants in Human Eosinophils J. Immunol., September 1, 1998; 161(5): 2574 - 2579. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iikura, M. Yamaguchi, T. Fujisawa, M. Miyamasu, T. Takaishi, Y. Morita, T. Iwase, I. Moro, K. Yamamoto, and K. Hirai Secretory IgA Induces Degranulation of IL-3-Primed Basophils J. Immunol., August 1, 1998; 161(3): 1510 - 1515. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takahashi, C. Murai, S. Shibata, Y. Munakata, T. Ishii, K. Ishii, T. Saitoh, T. Sawai, K. Sugamura, and T. Sasaki Human parvovirus B19 as a causative agent for rheumatoid arthritis PNAS, July 7, 1998; 95(14): 8227 - 8232. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Browning, Z. K. Pan, E. R. Prossnitz, and R. D. Ye Cell Type- and Developmental Stage-specific Activation of NF-kappa B by fMet-Leu-Phe in Myeloid Cells J. Biol. Chem., March 21, 1997; 272(12): 7995 - 8001. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |